Dr. Finger recently attended the 2016 Commission on Cancer Spring Meeting in Chicago. It was an opportunity to not only network with other cancer doctors from around the United States, but to plan and move forward a number of initiatives that will benefit the eye cancer care community and its patients. Dr. Finger serves as [..] Read More…
Dr. Paul T. Finger has been named one of America’s top doctors in 2016. Castle Connolly’s top doctors are nominated by their peers through an extensive survey process of thousands of American physicians. Each year, Castle Connolly receives nearly 100,000 nominations through this process. The organization’s research team screens medical education, training, board certifications, hospital [..] Read More…
In addition to his daily work treating his own patients at the NYECC, Dr. Finger is committed to advancing research that will benefit people diagnosed with eye cancer around the world. In that spirit, Dr. Finger is working with the Ophthalmic Oncology Task Force to create a database on vitreoretinal lymphoma that will ultimately lead [..] Read More…
The Ophthalmic Oncology Task Force, including doctors from The New York Eye Cancer Center, just published the results of one of the largest multi-center, international studies of eye cancer in history. Their findings were published in Ophthalmology, the most widely read journal in the discipline, from the American Academy of Ophthalmology. This study has shown [..] Read More…
The New York Eye Cancer Center is thrilled to announce it is the first clinic in the United States to use the state-of-art OCT2 imaging machine from Heidelberg Engineering. The machine was publicly released earlier this year and installed at NYECC the week before Christmas. It reflects Dr. Finger’s continuing commitment to provide cutting-edge, next-generation eye cancer care. Dr. Finger [..] Read More…
Dr. Paul Finger of the New York Eye Cancer Center is honored to be the sole author of all eye cancer sections in the latest edition of the Manual of Clinical Oncology. Published last September, the Manual is an essential reference text for clinicians treating and caring for oncology patients anywhere on the globe. The [..] Read More…
New York Eye Cancer Center Director Dr. Paul T. Finger has practiced medicine for over 30 years, but that doesn’t mean we’re set in our ways. Research into eye cancer is moving at breakneck speed, and the NYECC is always working to set the curve. We’re proud to announce the completion of two projects to [..] Read More…
Dr. Paul Finger has been named one of the top cancer doctors of 2015 in the United States by Newsweek. The magazine compiles its annual list through peer nominations and extensive research conducted by Castle Connolly Medical LTD: “The Castle Connolly physician-led research team makes tens of thousands of phone calls each year, talking with [..] Read More…
Radiation plays a key role in the treatment of ocular tumors. In many cases, radiation therapy offers a vision-sparing alternative to removing the eye. Dr. Finger has done extensive research in the use of eye and vision-saving radiation treatments and developed several pioneering techniques. Retina Today published Dr. Finger’s overview article on this research: “Radiation [..] Read More…
Two treatments for eye cancer pioneered by Dr. Paul Finger are saving vision and helping patients keep their eyes. Dr. Finger talked about these developments in a wide-ranging interview with Ivanhoe: “The most common primary intraocular tumor is melanoma. They are like malignant melanomas of the skin, but they are hidden inside the eye. At The [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
